会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明申请
    • AGENT FOR PROMOTING OSTEOGENESIS AND/OR INHIBITING BONE RESORPTION
    • 促进骨质疏松和/或抑制骨质疏松症的药剂
    • US20080206226A1
    • 2008-08-28
    • US12102552
    • 2008-04-14
    • Yoshikazu MoritaAtsushi SerizawaHiroaki MatsuyamaMutsumi MotouriHiroshi Kawakami
    • Yoshikazu MoritaAtsushi SerizawaHiroaki MatsuyamaMutsumi MotouriHiroshi Kawakami
    • A61K38/48A61P19/08
    • A61K38/1729A23K20/147A23K20/189A23L33/17A61K38/1725
    • Provided is a novel agent for promoting osteogenesis and/or inhibiting bone resorption, which: can be directly taken from daily meals by mouth for long periods without any trouble in taste; directly impart a promoting effect on osteogenesis and an inhibiting effect on bone resorption to the bone; and can be expected to have therapeutic effects for preventing or ameliorating/treating various bone diseases. The above agent includes, as an active ingredient, any one or more of β2-microglobulin, histone, complement component 3, monocyte chemotactic protein 1, lysozyme, ribonuclease, prothrombin, cytochrome P-450, plasminogen, transferrin, thrombin, plasmin, complement component 4, and β defensin, and enzymatic digestion products thereof. Those substances have a remarkable inhibiting effect on bone resorption by osteoclasts and/or a promoting effect on osteogenesis via promotion of the proliferation and differentiation of osteoblasts.
    • 本发明提供一种用于促进成骨和/或抑制骨吸收的新型药剂,其可以直接从日常饮食中口服长时间,没有任何麻烦的味道; 直接对骨骼发生促进作用,对骨吸收骨骼具有抑制作用; 并且可以预期具有预防或改善/治疗各种骨疾病的治疗效果。 作为活性成分,上述试剂包含β2 - 亚微球蛋白,组蛋白,补体成分3,单核细胞趋化蛋白1,溶菌酶,核糖核酸酶,凝血酶原,细胞色素P-450,纤溶酶原中的任何一种或多种 ,转铁蛋白,凝血酶,纤溶酶,补体成分4和β防御素及其酶消化产物。 这些物质通过促进成骨细胞的增殖和分化对破骨细胞的骨吸收和/或对成骨的促进作用具有显着的抑制作用。